Tag Archives: pharmaceutical companies

Cost of Treating Hepatitis C Is Soaring

Here is a fascinating picture from the Wall Street Journal, showing how much Medicare has been spending on hepatitis C treatments lately. You can see that the cost is rising dramatically: Keep in mind, however, that the new and expensive … Continue reading

Posted in Uncategorized | Tagged ,

These Americans Are Rich – Should We Celebrate?

American manufacturing has declined precipitously in the past few decades. Companies that were once the source of fabulous wealth for Americans – the U.S. Steel profits that enriched the Carnegie family, the Ford Motor F -1.29% Company profits that enriched … Continue reading

Posted in Uncategorized | Tagged ,

Side Effect Warnings Can Increase Pharmaceutical Sales

I must not be the only person to wonder how pharmaceutical companies succeed with direct to consumer advertisements when, stuck in the middle of all their TV ads, are those long lists of side effects. You know what I mean. … Continue reading

Posted in Behavioral Economics and Public Policy | Tagged ,

People in the US Are Footing the Bill for Switzerland's Medical Care

People have criticized The Affordable Care Act for amounting to a large transfer of wealth, from wealthy Americans to those not as well off. But the real transfer of wealth has been from United States to other developed nations, whose … Continue reading

Posted in Health Policy | Tagged , ,

Promoting Social Responsibility Among Pharmaceutical Companies

Last fall, an article in the New England Journal presented a powerful picture of just how much effort different pharmaceutical companies make to give poor people access to their products. Here is the picture from that article: The captains of … Continue reading

Posted in Health Policy | Tagged

What's Fair About Price Discrimination in Pharmaceutical Markets

A while back, DVD companies hoping to sell their products in countries like Poland faced a dilemma.  They could sell their products at a nice profit in the booming U.S. market, but to sell products in those other countries, they … Continue reading

Posted in Ethics | Tagged , ,

Bad News for Pharmaceutical Companies about Spending Trends

For years now, the pharmaceutical industry has justified its prices and its profits by reminding us that their products eventually go off patent, and are then offered cheaply to people around the world in generic form. They warned us that … Continue reading

Posted in Health Policy | Tagged ,

Great Picture on Drug Development Targets

Matthew Herper and Erin Carlyle at Forbes magazine recently put together a wonderful picture, showing what kinds of diseases pharmaceutical companies are targeting now in developing new drugs. The bigger the bubble, the larger the number of drugs under development. … Continue reading

Posted in Miscellaneous | Tagged